Désirée Bonci

6.5k total citations · 2 hit papers
37 papers, 3.6k citations indexed

About

Désirée Bonci is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Désirée Bonci has authored 37 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 19 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Désirée Bonci's work include MicroRNA in disease regulation (18 papers), Circular RNAs in diseases (13 papers) and Cancer-related molecular mechanisms research (6 papers). Désirée Bonci is often cited by papers focused on MicroRNA in disease regulation (18 papers), Circular RNAs in diseases (13 papers) and Cancer-related molecular mechanisms research (6 papers). Désirée Bonci collaborates with scholars based in Italy, United States and France. Désirée Bonci's co-authors include Ruggero De Maria, C Peschle, Valeria Coppola, Giovanni Muto, Antonio Addario, Maria Musumeci, Lorenzo Memeo, Mauro Biffoni, Leonardo D’Urso and Alfredo Pagliuca and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Désirée Bonci

36 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

2008 789 citations Désirée Bonci, Valeria Coppola et al. profile →
MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation

2005 606 citations Nadia Felli, Laura Fontana et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Désirée Bonci

Since Specialization

Citations

This map shows the geographic impact of Désirée Bonci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Désirée Bonci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Désirée Bonci more than expected).

Fields of papers citing papers by Désirée Bonci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Désirée Bonci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Désirée Bonci. The network helps show where Désirée Bonci may publish in the future.

Co-authorship network of co-authors of Désirée Bonci

This figure shows the co-authorship network connecting the top 25 collaborators of Désirée Bonci. A scholar is included among the top collaborators of Désirée Bonci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Désirée Bonci. Désirée Bonci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advancements in hepatocellular carcinoma diagnosis and treatment: liquid biopsy and surgical as precision treatment 2024 ·Hepatoma Research ·Alessandro Mazzotta, Désirée Bonci	1
2	C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 2017 ·Oncogene ·Alessio Cannistraci, G. Federici, Antonio Addario, Anna Laura Di Pace, Ludovica Grassi, Giovanni Muto, Devis Collura, Michele Signore, (unknown), Steno Sentinelli, Giuseppe Simone, Manuela Costantini, Simona Nanni, Antonella Farsetti, Valeria Coppola, Ruggero De Maria, Désirée Bonci	35
3	A microRNA code for prostate cancer metastasis 2015 ·Oncogene ·Désirée Bonci, Valeria Coppola, Michele Patrizii, Antonio Addario, Alessio Cannistraci, Federica Francescangeli, Raffaella Pecci, Giovanni Muto, Devis Collura, R. Bedini, Ann Zeuner, M Valtieri, Steno Sentinelli, Maria Serena Benassi, Michele Gallucci, Paolo Carlini, Stefano Piccolo, Ruggero De Maria	103
4	Functional Role of MicroRNAs in Prostate Cancer and Therapeutic Opportunities 2013 ·Critical Reviews™ in Oncogenesis ·Marcello Maugeri‐Saccà, Valeria Coppola, Ruggero De Maria, Désirée Bonci	5
5	Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia 2011 ·Genes and Immunity ·Siddha Kasar, Erica Salerno, Yuan Yao, Chingiz Underbayev, (unknown), (unknown), Helen Fernandes, Désirée Bonci, Antonio Addario, Fermina M. Mazzella, Elizabeth Raveché	59
6	MicroRNA-21 as Therapeutic Target in Cancer and Cardiovascular Disease 2010 ·Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) ·Désirée Bonci	44
7	MicroRNA-21 as Therapeutic Target in Cancer and Cardiovascular Disease 2010 ·Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) ·Désirée Bonci	7
8	MicroRNAs and prostate cancer 2009 ·Endocrine Related Cancer ·Valeria Coppola, Ruggero De Maria, Désirée Bonci	121
9	THE MIR-15A/MIR-16-1 CLUSTER CONTROLS PROSTATE CANCER PROGRESSION CONTROL BY TARGETING OF MULTIPLE ONCOGENIC ACTIVITIES 2009 ·The Journal of Urology ·Désirée Bonci, Valeria Coppola, Maria Musumeci, Antonio Addario, Leonardo D’Urso, Devis Collura, C Peschle, Ruggero De Maria, Giovanni Muto	2
10	Manipulating the Cell Differentiation Through Lentiviral Vectors 2009 ·Methods in molecular biology ·Valeria Coppola, Cesare Galli, Maria Musumeci, Désirée Bonci	3
11	Green fluorescent protein incorporation by mouse myoblasts may yield false evidence of myogenic differentiation of human haematopoietic stem cells 2008 ·Acta Physiologica ·Maria Amalia Di Castro, Désirée Bonci, Maria Musumeci, Francesca Grassi	2
12	The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice 2008 ·PLoS ONE ·Neri Mercatelli, Valeria Coppola, Désirée Bonci, (unknown), Arianna Costantini, Marco Guadagnoli, Elena Bonanno, Giovanni Muto, Giovanni Vanni Frajese, Ruggero De Maria, Luigi Giusto Spagnoli, Maria Giulia Farace, Silvia Anna Ciafrè	211
13	Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity 2008 ·Haematologica ·Désirée Bonci, Maria Musumeci, Valeria Coppola, Antonio Addario, Concetta Conticello, M. Hahne, Massimo Gulisano, F Grignani, Ruggero De Maria	7
14	A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells 2007 ·Gene Therapy ·Pasquale Gallo, Settimio Grimaldi, Michael V.G. Latronico, Désirée Bonci, Alfredo Pagliuca, Simonetta Ausoni, C Peschle, Gianluigi Condorelli	28
15	Lentiviral Transduction of Human Postnatal Skeletal (Stromal, Mesenchymal) Stem Cells: In Vivo Transplantation and Gene Silencing 2006 ·Calcified Tissue International ·Stefania Piersanti, Benedetto Sacchetti, Alessia Funari, Silvia Di Cesare, Désirée Bonci, (unknown), C Peschle, Mara Riminucci, P. Bianco, Isabella Saggio	24
16	MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation breakdown → 2005 ·Proceedings of the National Academy of Sciences ·Nadia Felli, Laura Fontana, Elvira Pelosi, Rosanna Botta, Désirée Bonci, Francesco Facchiano, Francesca Liuzzi, Valentina Lulli, Ornella Morsilli, Simona Santoro, M Valtieri, George A. Calin, Chang‐Gong Liu, Antonio Sorrentino, Carlo M. Croce, C Peschle	606
17	Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line 2005 ·Cell Death and Differentiation ·Simona Coppola, Laura Narciso, (unknown), Désirée Bonci, Luana Calabrò, Ornella Morsilli, Marco Gabbianelli, Ruggero De Maria, Ugo Testa, C Peschle	27
18	Heart infarct in NOD‐SCID mice: Therapeutic vasculogenesis by transplantation of human CD34 ⁺ cells and low dose CD34 ⁺ KDR ⁺ cells 2004 ·The FASEB Journal ·Rosanna Botta, Erhe Gao, Giorgio Stassi, Désirée Bonci, Elvira Pelosi, Donna R. Zwas, Mariella Patti, Lucrezia Colonna, Marta Baiocchi, Simona Coppola, (unknown), Gianluigi Condorelli, C Peschle	84
19	Formation of PML/RARα high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RARα-mediated retinoic acid response 1999 ·Oncogene ·F Grignani, Vania Gelmetti, Mirco Fanelli, Daniela Rogaia, Silvia De Matteis, Fabiana Fosca Ferrara, Désirée Bonci, Fausto Grignani, Clara Nervi, Pier Giuseppe Pelicci	37
20	Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 1999 ·Nature ·Ruggero De Maria, Ann Zeuner, Adriana Eramo, (unknown), Désirée Bonci, F Grignani, Srinivasa M. Srinivasula, Emad S. Alnemri, Ugo Testa, C Peschle	324

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact